ParkinsonFranceV1, PascalFrancis, Curation, bibRecord, 000156

Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation

Identifieur interne : 000156 ( PascalFrancis/Curation ); précédent : 000155; suivant : 000157

Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation

Auteurs : Teiichi Yamane [France] ; Pierre Jaïs [France] ; Dipen C. Shah [France] ; Mélèze Hocini [France] ; JING TIAN PENG [France] ; Isabel Deisenhofer [France] ; Jacques Clementy [France] ; Michel Haïssaguerre [France]

Source :

Circulation : (New York, N.Y.) [ 0009-7322 ] ; 2000.

RBID : Pascal:01-0036991

Descripteurs français

Pascal (Inist)
- Wolff Parkinson White syndrome, Homme, Traitement, Cathétérisme, Technique, Irrigation, Efficacité traitement, Toxicité, Irradiation haute fréquence, Voie conduction accessoire.
Wicri :
- topic : Homme, Irrigation.

English descriptors

KwdEn :
- Catheterization, Human, Irrigation, Radiofrequency irradiation, Technique, Toxicity, Treatment, Treatment efficiency, Wolff Parkinson White syndrome.

Abstract

Background-Radiofrequency catheter ablation of accessory pathways (APs) is very effective in all but a minority of patients. We examined the usefulness and safety of irrigated-tip catheters in treating patients with APs resistant to conventional catheter ablation. Methods and Results-Among 314 APs in 301 consecutive patients, conventional ablation failed to eliminate AP conduction in 18 APs in 18 patients (5.7%), 6 of which were located in the left free wall, 5 in the middle/posterior-septal space, and 7 inside the coronary sinus (CS) or its tributaries. Irrigated-tip catheter ablation was subsequently performed with temperature control mode (target temperature, 50°C), a moderate saline flow rate (17 mL/min), and a power limit of 50 W (outside CS) or 20 to 30 W (inside CS) at previously resistant sites. Seventeen of the 18 resistant APs (94%) were successfully ablated with a median of 3 applications using irrigated-tip catheters. A significant increase in power delivery was achieved (20.3 ± 11.5 versus 36.5 ± 8.2 W; P<0.01) with irrigated-tip catheters, irrespective of the AP location, particularly inside the CS or its tributaries. No serious complications occurred. Conclusions-Irrigated-tip catheter ablation is safe and effective in eliminating AP conduction resistant to conventional catheters, irrespective of the location.

A01	`01`	`1`		`@0 0009-7322`
A02	`01`			`@0 CIRCAZ`
A03		`1`		`@0 Circulation : (N. Y. N.Y.)`
A05				`@2 102`
A06				`@2 21`
A08	`01`	`1`	`ENG`	`@1 Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation`
A11	`01`	`1`		`@1 YAMANE (Teiichi)`
A11	`02`	`1`		`@1 JAÏS (Pierre)`
A11	`03`	`1`		`@1 SHAH (Dipen C.)`
A11	`04`	`1`		`@1 HOCINI (Mélèze)`
A11	`05`	`1`		`@1 JING TIAN PENG`
A11	`06`	`1`		`@1 DEISENHOFER (Isabel)`
A11	`07`	`1`		`@1 CLEMENTY (Jacques)`
A11	`08`	`1`		`@1 HAÏSSAGUERRE (Michel)`
A14	`01`			`@1 Hôpital Cardiologique du Haut-Lévêque @2 Bordeaux-Pessac @3 FRA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut. @Z 8 aut.`
A20				`@1 2565-2568`
A21				`@1 2000`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 5907 @5 354000092829560020`
A44				`@0 0000 @1 © 2001 INIST-CNRS. All rights reserved.`
A45				`@0 7 ref.`
A47	`01`	`1`		`@0 01-0036991`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Circulation : (New York, N.Y.)`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Background-Radiofrequency catheter ablation of accessory pathways (APs) is very effective in all but a minority of patients. We examined the usefulness and safety of irrigated-tip catheters in treating patients with APs resistant to conventional catheter ablation. Methods and Results-Among 314 APs in 301 consecutive patients, conventional ablation failed to eliminate AP conduction in 18 APs in 18 patients (5.7%), 6 of which were located in the left free wall, 5 in the middle/posterior-septal space, and 7 inside the coronary sinus (CS) or its tributaries. Irrigated-tip catheter ablation was subsequently performed with temperature control mode (target temperature, 50°C), a moderate saline flow rate (17 mL/min), and a power limit of 50 W (outside CS) or 20 to 30 W (inside CS) at previously resistant sites. Seventeen of the 18 resistant APs (94%) were successfully ablated with a median of 3 applications using irrigated-tip catheters. A significant increase in power delivery was achieved (20.3 ± 11.5 versus 36.5 ± 8.2 W; P<0.01) with irrigated-tip catheters, irrespective of the AP location, particularly inside the CS or its tributaries. No serious complications occurred. Conclusions-Irrigated-tip catheter ablation is safe and effective in eliminating AP conduction resistant to conventional catheters, irrespective of the location.
C02	`01`	`X`		`@0 002B26E`
C03	`01`	`X`	`FRE`	`@0 Wolff Parkinson White syndrome @5 01`
C03	`01`	`X`	`ENG`	`@0 Wolff Parkinson White syndrome @5 01`
C03	`01`	`X`	`SPA`	`@0 Wolff Parkinson White síndrome @5 01`
C03	`02`	`X`	`FRE`	`@0 Homme @5 02`
C03	`02`	`X`	`ENG`	`@0 Human @5 02`
C03	`02`	`X`	`SPA`	`@0 Hombre @5 02`
C03	`03`	`X`	`FRE`	`@0 Traitement @5 03`
C03	`03`	`X`	`ENG`	`@0 Treatment @5 03`
C03	`03`	`X`	`SPA`	`@0 Tratamiento @5 03`
C03	`04`	`X`	`FRE`	`@0 Cathétérisme @5 04`
C03	`04`	`X`	`ENG`	`@0 Catheterization @5 04`
C03	`04`	`X`	`SPA`	`@0 Cateterización @5 04`
C03	`05`	`X`	`FRE`	`@0 Technique @5 05`
C03	`05`	`X`	`ENG`	`@0 Technique @5 05`
C03	`05`	`X`	`SPA`	`@0 Técnica @5 05`
C03	`06`	`X`	`FRE`	`@0 Irrigation @5 06`
C03	`06`	`X`	`ENG`	`@0 Irrigation @5 06`
C03	`06`	`X`	`SPA`	`@0 Irrigación @5 06`
C03	`07`	`X`	`FRE`	`@0 Efficacité traitement @5 07`
C03	`07`	`X`	`ENG`	`@0 Treatment efficiency @5 07`
C03	`07`	`X`	`SPA`	`@0 Eficacia tratamiento @5 07`
C03	`08`	`X`	`FRE`	`@0 Toxicité @5 08`
C03	`08`	`X`	`ENG`	`@0 Toxicity @5 08`
C03	`08`	`X`	`SPA`	`@0 Toxicidad @5 08`
C03	`09`	`X`	`FRE`	`@0 Irradiation haute fréquence @5 09`
C03	`09`	`X`	`ENG`	`@0 Radiofrequency irradiation @5 09`
C03	`09`	`X`	`SPA`	`@0 Irradiación alta frecuencia @5 09`
C03	`10`	`X`	`FRE`	`@0 Voie conduction accessoire @4 INC @5 86`
C07	`01`	`X`	`FRE`	`@0 Appareil circulatoire pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cardiovascular disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Cardiopathie @5 38`
C07	`02`	`X`	`ENG`	`@0 Heart disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Cardiopatía @5 38`
C07	`03`	`X`	`FRE`	`@0 Trouble rythme cardiaque @5 39`
C07	`03`	`X`	`ENG`	`@0 Arrhythmia @5 39`
C07	`03`	`X`	`SPA`	`@0 Arritmia @5 39`
C07	`04`	`X`	`FRE`	`@0 Trouble excitabilité @5 40`
C07	`04`	`X`	`ENG`	`@0 Excitability disorder @5 40`
C07	`04`	`X`	`SPA`	`@0 Trastorno excitabilidad @5 40`
C07	`05`	`X`	`FRE`	`@0 Trouble conduction @5 41`
C07	`05`	`X`	`ENG`	`@0 Conduction disorder @5 41`
C07	`05`	`X`	`SPA`	`@0 Trastorno conducción @5 41`
C07	`06`	`X`	`FRE`	`@0 Préexcitation ventriculaire syndrome @5 42`
C07	`06`	`X`	`ENG`	`@0 Preexcitation ventricular syndrome @5 42`
C07	`06`	`X`	`SPA`	`@0 Preexcitación ventricular síndrome @5 42`
C07	`07`	`X`	`FRE`	`@0 Traitement instrumental @5 43`
C07	`07`	`X`	`ENG`	`@0 Instrumentation therapy @5 43`
C07	`07`	`X`	`SPA`	`@0 Tratamiento instrumental @5 43`
N21				`@1 022`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001282

Links to Exploration step

Pascal:01-0036991

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation</title>
<author><name sortKey="Yamane, Teiichi" sort="Yamane, Teiichi" uniqKey="Yamane T" first="Teiichi" last="Yamane">Teiichi Yamane</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Jais, Pierre" sort="Jais, Pierre" uniqKey="Jais P" first="Pierre" last="Jaïs">Pierre Jaïs</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Shah, Dipen C" sort="Shah, Dipen C" uniqKey="Shah D" first="Dipen C." last="Shah">Dipen C. Shah</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Hocini, Meleze" sort="Hocini, Meleze" uniqKey="Hocini M" first="Mélèze" last="Hocini">Mélèze Hocini</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Jing Tian Peng" sort="Jing Tian Peng" uniqKey="Jing Tian Peng" last="Jing Tian Peng">JING TIAN PENG</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Deisenhofer, Isabel" sort="Deisenhofer, Isabel" uniqKey="Deisenhofer I" first="Isabel" last="Deisenhofer">Isabel Deisenhofer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Clementy, Jacques" sort="Clementy, Jacques" uniqKey="Clementy J" first="Jacques" last="Clementy">Jacques Clementy</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Haissaguerre, Michel" sort="Haissaguerre, Michel" uniqKey="Haissaguerre M" first="Michel" last="Haïssaguerre">Michel Haïssaguerre</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">01-0036991</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 01-0036991 INIST</idno>
<idno type="RBID">Pascal:01-0036991</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001282</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000156</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation</title>
<author><name sortKey="Yamane, Teiichi" sort="Yamane, Teiichi" uniqKey="Yamane T" first="Teiichi" last="Yamane">Teiichi Yamane</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Jais, Pierre" sort="Jais, Pierre" uniqKey="Jais P" first="Pierre" last="Jaïs">Pierre Jaïs</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Shah, Dipen C" sort="Shah, Dipen C" uniqKey="Shah D" first="Dipen C." last="Shah">Dipen C. Shah</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Hocini, Meleze" sort="Hocini, Meleze" uniqKey="Hocini M" first="Mélèze" last="Hocini">Mélèze Hocini</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Jing Tian Peng" sort="Jing Tian Peng" uniqKey="Jing Tian Peng" last="Jing Tian Peng">JING TIAN PENG</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Deisenhofer, Isabel" sort="Deisenhofer, Isabel" uniqKey="Deisenhofer I" first="Isabel" last="Deisenhofer">Isabel Deisenhofer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Clementy, Jacques" sort="Clementy, Jacques" uniqKey="Clementy J" first="Jacques" last="Clementy">Jacques Clementy</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Haissaguerre, Michel" sort="Haissaguerre, Michel" uniqKey="Haissaguerre M" first="Michel" last="Haïssaguerre">Michel Haïssaguerre</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Circulation : (New York, N.Y.)</title>
<title level="j" type="abbreviated">Circulation : (N. Y. N.Y.)</title>
<idno type="ISSN">0009-7322</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Circulation : (New York, N.Y.)</title>
<title level="j" type="abbreviated">Circulation : (N. Y. N.Y.)</title>
<idno type="ISSN">0009-7322</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Catheterization</term>
<term>Human</term>
<term>Irrigation</term>
<term>Radiofrequency irradiation</term>
<term>Technique</term>
<term>Toxicity</term>
<term>Treatment</term>
<term>Treatment efficiency</term>
<term>Wolff Parkinson White syndrome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Wolff Parkinson White syndrome</term>
<term>Homme</term>
<term>Traitement</term>
<term>Cathétérisme</term>
<term>Technique</term>
<term>Irrigation</term>
<term>Efficacité traitement</term>
<term>Toxicité</term>
<term>Irradiation haute fréquence</term>
<term>Voie conduction accessoire</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Irrigation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background-Radiofrequency catheter ablation of accessory pathways (APs) is very effective in all but a minority of patients. We examined the usefulness and safety of irrigated-tip catheters in treating patients with APs resistant to conventional catheter ablation. Methods and Results-Among 314 APs in 301 consecutive patients, conventional ablation failed to eliminate AP conduction in 18 APs in 18 patients (5.7%), 6 of which were located in the left free wall, 5 in the middle/posterior-septal space, and 7 inside the coronary sinus (CS) or its tributaries. Irrigated-tip catheter ablation was subsequently performed with temperature control mode (target temperature, 50°C), a moderate saline flow rate (17 mL/min), and a power limit of 50 W (outside CS) or 20 to 30 W (inside CS) at previously resistant sites. Seventeen of the 18 resistant APs (94%) were successfully ablated with a median of 3 applications using irrigated-tip catheters. A significant increase in power delivery was achieved (20.3 ± 11.5 versus 36.5 ± 8.2 W; P<0.01) with irrigated-tip catheters, irrespective of the AP location, particularly inside the CS or its tributaries. No serious complications occurred. Conclusions-Irrigated-tip catheter ablation is safe and effective in eliminating AP conduction resistant to conventional catheters, irrespective of the location.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0009-7322</s0>
</fA01>
<fA02 i1="01"><s0>CIRCAZ</s0>
</fA02>
<fA03 i2="1"><s0>Circulation : (N. Y. N.Y.)</s0>
</fA03>
<fA05><s2>102</s2>
</fA05>
<fA06><s2>21</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>YAMANE (Teiichi)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>JAÏS (Pierre)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SHAH (Dipen C.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HOCINI (Mélèze)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>JING TIAN PENG</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>DEISENHOFER (Isabel)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>CLEMENTY (Jacques)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>HAÏSSAGUERRE (Michel)</s1>
</fA11>
<fA14 i1="01"><s1>Hôpital Cardiologique du Haut-Lévêque</s1>
<s2>Bordeaux-Pessac</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA20><s1>2565-2568</s1>
</fA20>
<fA21><s1>2000</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>5907</s2>
<s5>354000092829560020</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2001 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>7 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>01-0036991</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Circulation : (New York, N.Y.)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background-Radiofrequency catheter ablation of accessory pathways (APs) is very effective in all but a minority of patients. We examined the usefulness and safety of irrigated-tip catheters in treating patients with APs resistant to conventional catheter ablation. Methods and Results-Among 314 APs in 301 consecutive patients, conventional ablation failed to eliminate AP conduction in 18 APs in 18 patients (5.7%), 6 of which were located in the left free wall, 5 in the middle/posterior-septal space, and 7 inside the coronary sinus (CS) or its tributaries. Irrigated-tip catheter ablation was subsequently performed with temperature control mode (target temperature, 50°C), a moderate saline flow rate (17 mL/min), and a power limit of 50 W (outside CS) or 20 to 30 W (inside CS) at previously resistant sites. Seventeen of the 18 resistant APs (94%) were successfully ablated with a median of 3 applications using irrigated-tip catheters. A significant increase in power delivery was achieved (20.3 ± 11.5 versus 36.5 ± 8.2 W; P<0.01) with irrigated-tip catheters, irrespective of the AP location, particularly inside the CS or its tributaries. No serious complications occurred. Conclusions-Irrigated-tip catheter ablation is safe and effective in eliminating AP conduction resistant to conventional catheters, irrespective of the location.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B26E</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Wolff Parkinson White syndrome</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Wolff Parkinson White syndrome</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Wolff Parkinson White síndrome</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Homme</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Human</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Hombre</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Traitement</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Treatment</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Cathétérisme</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Catheterization</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Cateterización</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Technique</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Technique</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Técnica</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Irrigation</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Irrigation</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Irrigación</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Efficacité traitement</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Treatment efficiency</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Eficacia tratamiento</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Toxicité</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Toxicity</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Toxicidad</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Irradiation haute fréquence</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Radiofrequency irradiation</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Irradiación alta frecuencia</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Voie conduction accessoire</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Cardiopathie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Heart disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Cardiopatía</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Trouble rythme cardiaque</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Arrhythmia</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Arritmia</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Trouble excitabilité</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Excitability disorder</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Trastorno excitabilidad</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Trouble conduction</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Conduction disorder</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Trastorno conducción</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Préexcitation ventriculaire syndrome</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Preexcitation ventricular syndrome</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Preexcitación ventricular síndrome</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Traitement instrumental</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Instrumentation therapy</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Tratamiento instrumental</s0>
<s5>43</s5>
</fC07>
<fN21><s1>022</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000156 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000156 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:01-0036991
   |texte=   Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation

Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri